{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:32:41Z","timestamp":1771032761397,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Diffuse large B-cell lymphoma (DLBCL) represents the most common form of non-Hodgkin lymphoma and is characterized by an aggressive natural history. It often presents with rapid symptom development and disease progression. Most lymphomas are inherently radiosensitive, which allows for effective disease control from relatively low radiation doses. We report a case of a dramatic radiotherapy response in a necrotic diffuse large B-cell lymphoma mass in an elderly patient with early-stage diffuse large B-cell lymphoma, illustrating the potential for palliative radiotherapy to reduce disease burden in patients not fit for systemic therapy. There is no current consensus recommendation for radiotherapy treatment in this setting.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 97-year-old Caucasian woman presented to the emergency department of our institution with a painful, malodorous, necrotic right upper neck mass, which had progressed over a two-month period. Investigations confirmed stage 1A diffuse large B-cell lymphoma. Palliative radiotherapy was delivered to a dose of 25 Gray (Gy) in five fractions on alternate days over two consecutive weeks. After four months, the mass completely resolved with no residual symptoms.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Dramatic responses resulting in durable local control and improvement in quality of life are achievable with palliative radiotherapy, owing to the radiosensitivity of diffuse large B-cell lymphoma.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-020-02438-1","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:04:59Z","timestamp":1595891099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dramatic radiotherapy response in a necrotic lymphoma mass: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Nicholas","family":"McNeil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gorayski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Blunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"2438_CR1","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"International Lymphoma Study Group","year":"1997","unstructured":"International Lymphoma Study Group. Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"key":"2438_CR2","unstructured":"Freedman AS, Aster JC. Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma. In: UpToDate. Lister, A (Ed). UpToDate. Waltham, MA, USA. 2012."},{"key":"2438_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, M\u00fcller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275\u201382.","journal-title":"Blood."},{"issue":"Suppl 5","key":"2438_CR4","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116\u201325.","journal-title":"Ann Oncol"},{"key":"2438_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13014-016-0690-y","volume":"11","author":"M Zimmermann","year":"2016","unstructured":"Zimmermann M, Oehler C, Mey U, Ghadjar P, Zwahlen DR. Radiotherapy for non-Hodgkin\u2019s lymphoma: still standard practice and not an outdated treatment option. Radiat Oncol. 2016;11:110.","journal-title":"Radiat Oncol"},{"key":"2438_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3816\/CLM.2008.n.032","volume":"8","author":"V Murthy","year":"2008","unstructured":"Murthy V, Thomas K, Foo K, Cunningham D, Johnson B, Norman A, Horwich A. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Clin Lymphoma Myeloma. 2008;8:241\u20135.","journal-title":"Clin Lymphoma Myeloma"},{"key":"2438_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hon.2368","volume":"35","author":"C Furlan","year":"2017","unstructured":"Furlan C, Canzonieri V, Spina M, Michieli M, Ermacora A, Maestro R, Piccinin S, Bomben R, Dal Bo M, Trovo M, Gattei V. Low-dose radiotherapy in diffuse large B-cell lymphoma. Hematol Oncol. 2017;35:472\u20139.","journal-title":"Hematol Oncol"},{"key":"2438_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.rpor.2016.07.009","volume":"21","author":"O Tanaka","year":"2016","unstructured":"Tanaka O, Oguchi M, Iida T, Kasahara S, Goto H, Takahashi T. Low dose palliative radiotherapy for refractory aggressive lymphoma. Rep Pract Oncol Radiother. 2016;21:495\u20139.","journal-title":"Rep Pract Oncol Radiother."},{"key":"2438_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.1866","volume":"96(2 Suppl)","author":"JL Brady","year":"2016","unstructured":"Brady JL, Attallah H, Mikhaeel NG. Outcome of low-dose palliative radiation therapy in relapsed or refractory high-grade non-Hodgkin lymphoma [abstract]. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E493.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2438_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijrobp.2017.12.005","volume":"100","author":"AK Ng","year":"2018","unstructured":"Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S. Role of radiation therapy in patients with relapsed\/refractory diffuse large B-cell lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018;100(3):652\u201369.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2438_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A. Modern radiation therapy for nodal non-Hodgkin lymphoma\u2014target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2014;89(1):49\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2438_CR12","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Non-Hodgkin\u2019s Lymphoma. Version 3. 2019. http:\/\/www.nccn.org. Accessed 20 Dec 2019."},{"issue":"3 Suppl","key":"2438_CR13","doi-asserted-by":"publisher","first-page":"E365","DOI":"10.1016\/j.ijrobp.2018.07.1094","volume":"102","author":"J Wong","year":"2018","unstructured":"Wong J, Pickles T, Connors JM, Aquino-Parsons C, Sehn L, Freeman C, Lo AC. Efficacy of palliative radiation therapy (RT) for diffuse large B-cell lymphoma: a population-based retrospective review [abstract]. Int J Radiat Oncol Biol Phys. 2018;102(3 Suppl):E365.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-020-02438-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:34:32Z","timestamp":1627428872000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02438-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02438-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images, and this written consent was countersigned by her medical agent. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial or nonfinancial competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}